Manufacturers Life Insurance Company, The Immunity Bio, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 81,629 shares of IBRX stock, worth $519,160. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,629
Previous 60,178
35.65%
Holding current value
$519,160
Previous $302,000
45.03%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding IBRX
# of Institutions
193Shares Held
66.7MCall Options Held
2.27MPut Options Held
3.23M-
State Street Corp Boston, MA14.2MShares$90.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$86.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$66 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.48MShares$22.1 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.55MShares$9.85 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $2.55B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...